For Employers

Right medicine. Right patient. Right dosage.

For most employers, the cost of prescription drugs is rising at double digit rates (in 2016, 11.3% for active employees and retirees; 18.7% for specialty drugs).  Frustrated with lack of transparency and unclear business dealings between PBMs and drug manufacturers, employers are demanding cost saving strategies that require a fundamentally different approach to the delivery system and benefit design. They are also defining new rules of engagement and implementing new contractual requirements between those who manage the spend.

Employers need assurance that medication decisions are based on clinical efficacy and safety. We want to better understand how investments in high-value drugs impact clinical outcomes.

The Institute is a vehicle to explore new and innovative payment and value-based contracting arrangements. It’s an opportunity to explore expanding roles and functions within team-based, collaborative, patient-centered care.

Are you doing all you can to enable better health for your employee population, better care for employees, and improved plan performance?

Join us. Together we can transform practice, use evidence wisely and implement real policy solutions.

Click to join

Fewer medication errors.

Illness and death resulting from non-optimized medication therapy (wrong drug, skipped dose, drugs that make you sick) cost $528.4 billion annually, equivalent to 16% of total U.S. health care expenditures in 2016. It’s time to reduce errors.

  • Adverse drug events account for nearly 700,000 emergency department visits a year.
  • Adverse drug events account for nearly 100,000 hospitalizations a year.

Better results for your health care spend.

Prescription medications account for $1 of every $4 spent by commercial health plans. Work with us to gain insight into cost-effective, high-quality and appropriate medications and gene therapies that will unlock innovative solutions in support of value-based purchasing strategies.

Delivery system solutions today.

Impacting practice, payment and policy is not a pipe dream. We can connect medication and optimize its use with clinical decision making. We can get people to clinical goal with appropriate use of medication. We can save lives, and we can save money.

Action changes things.

Back To Top
Search